Active ingredient
Ixazomib
3 finished FDA listings contain Ixazomib as their only active ingredient.
FDA NDC Directory
- Ingredient names as written by FDA
- IXAZOMIB CITRATE
- Dosage forms
- Capsule
- Routes
- Oral
- Manufacturers / labelers
- 1
- Strengths listed
- 2.3 mg/1 · 3 mg/1 · 4 mg/1
- Brand names in FDA listings
- Ninlaro
RxNorm (National Library of Medicine)
Ingredient concept RxCUI 1723735
Drugs@FDA applications
Linked only where the FDA listing’s application number matches Drugs@FDA exactly. A listing in the NDC Directory does not by itself mean FDA approval.
| Application | Sponsor | Original approval | Listings |
|---|---|---|---|
| NDA 208462 | TAKEDA PHARMS USA | 2015-11-20 | 3 |
Official labeling on DailyMed
- NINLARO (IXAZOMIB) CAPSULE [TAKEDA PHARMACEUTICALS AMERICA, INC.] · version 18 · 2026-08-17
Sources: FDA NDC Directory (2026-09-29), RxNorm, Drugs@FDA, DailyMed. Each source’s facts are shown separately as published.